4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 1,080.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,120.00
  • 52 Week Low: 500.00
  • Currency: UK Pounds
  • Shares Issued: 12.81m
  • Volume: 739
  • Market Cap: £138.30m

4basebio Overview

4basebio UK Societas ("4bb" or "the Company") is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing Good Manufacturing Practice ("GMP") grade DNA, suitable for use in gene therapies and DNA vaccines.

Key Personnel

CEO: Heikki Lanckriet
CFO: David John Roth
Independent Non-Executive Director: Maria Del Pilar de la Huerta
Non-Executive Chairman: Timothy Paul McCarthy
Non-Executive Dir: Hansjörg Plaggemars, Joseph Manuel Fernández

Contact Details

Address: 25 Norman Way, Over, Cambridge, United Kingdom, CB24 5QE
Phone: +44 (0)1223 967943
Website: http://www.4basebio.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BMCLYF79

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,080.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,120.00
52 Week Low 500.00
Volume 739
Shares Issued 12.81m
Market Cap £138.30m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.51% below the market average70.51% below the market average70.51% below the market average70.51% below the market average70.51% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Price Trend
98.04% above the market average98.04% above the market average98.04% above the market average98.04% above the market average98.04% above the market average
96.36% above the sector average96.36% above the sector average96.36% above the sector average96.36% above the sector average96.36% above the sector average
Income Not Available
Growth
35.04% below the market average35.04% below the market average35.04% below the market average35.04% below the market average35.04% below the market average
48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average

4basebio Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
14:25 182 @ 1,096.00p
13:48 500 @ 1,061.00p
12:07 57 @ 1,096.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page